Back to Search
Start Over
CD34+ Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation
- Source :
- Blood; December 2016, Vol. 128 Issue: 22 p2300-2300, 1p
- Publication Year :
- 2016
-
Abstract
- Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used in the treatment of a variety of hematologic diseases. However, allo-HSCT can be associated with many complications, including poor graft function early after transplant requiring long-lasting supportive care. In the literature, the incidence of poor graft function post allo-HSCT has been reported to range from 4 to 27%.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 128
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56686359
- Full Text :
- https://doi.org/10.1182/blood.V128.22.2300.2300